Now showing items 1-3 of 3
Cardiovascular drug monitoring using quantitative LC-HRMS analysis of self-collected micro-volume blood samples
Background Evidence suggests that ˃50% of cardiovascular (CVD) disease patients do not adhere to treatment thus impacting on patient health, additional healthcare costs and medicines wastage. DBS microsampling combined ...
LC-HRMS analysis of 133 patient micro-volume blood samples to allow clinical assessment of medication adherence
(The Association for Mass Spectrometry: Applications to the Clinical Lab, 2017-01-25)
133 DBS card/VAMS micro-volume blood samples were analysed by LC-HRMS to determine if therapeutic levels of the prescribed cardiovascular (CVD) drugs were present. This research focussed on the top 11 UK prescribed CVD ...